Related Experiment Videos
Defect in modification at the anticodon wobble nucleotide of mitochondrial tRNA(Lys) with the MERRF encephalomyopathy
T Yasukawa1, T Suzuki, N Ishii
1Department of Chemistry, Graduate School of Engineering, University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, Japan. kw@kw1.t.u-tokyo.ac.jp
Abstract:
A mitochondrial tRNA(Lys) gene mutation at nucleotide position 8344 is responsible for the myoclonus epilepsy associated with ragged-red fibers (MERRF) subgroup of mitochondrial encephalomyopathies. Here, we show that normally modified uridine at the anticodon wobble position remains unmodified in the purified mutant tRNA(Lys). We have reported a similar modification defect at the same position in two mutant mitochondrial tRNAs(Leu)(UUR) in another subgroup, mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes (MELAS), indicating this defect is common in the two kinds of tRNA molecules with the respective mutations of the two major mitochondrial encephalomyopathies. We therefore suggest the defect in the anticodon is responsible, through the translational process, for the pathogenesis of mitochondrial diseases.
Insights
Mitochondrial disease mutations, like those in MERRF and MELAS, cause defects in transfer RNA (tRNA) modification. This anticodon defect likely drives the disease process through impaired translation.
Area of Science:
- Mitochondrial biology
- Molecular genetics
- Neuroscience
Background:
- Mitochondrial encephalomyopathies, such as MERRF and MELAS, are severe neurological disorders.
- These diseases are linked to mutations in mitochondrial DNA, affecting energy production.
Purpose of the Study:
- To investigate the molecular consequences of a specific mitochondrial tRNA(Lys) mutation in MERRF.
- To determine if tRNA modification defects are a common feature in major mitochondrial encephalomyopathies.
Main Methods:
- Purification of mutant mitochondrial tRNA(Lys) from MERRF patients.
- Analysis of nucleotide modifications at the anticodon wobble position of the purified tRNA.
- Comparison with previously reported data on mutant mitochondrial tRNAs(Leu)(UUR) in MELAS.
Main Results:
- The study identified a lack of uridine modification at the anticodon wobble position in mutant tRNA(Lys) from MERRF patients.
- This modification defect mirrors findings in mutant tRNAs(Leu)(UUR) associated with MELAS.
- The defect is common to tRNA molecules involved in two major mitochondrial encephalomyopathies.
Conclusions:
- A common defect in anticodon modification exists in tRNA molecules associated with MERRF and MELAS.
- This anticodon modification defect is proposed to be a key factor in the pathogenesis of mitochondrial diseases.
- The defect likely impairs the translational process, leading to cellular dysfunction and disease symptoms.